Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Treasury Shares (2023 - 2024)

Coya Therapeutics (COYA) has disclosed Treasury Shares for 2 consecutive years, with $21500.0 as the latest value for Q4 2024.

  • Quarterly Treasury Shares rose 30.3% to $21500.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $21500.0 through Dec 2024, up 30.3% year-over-year, with the annual reading at $21500.0 for FY2024, 30.3% up from the prior year.
  • Treasury Shares hit $21500.0 in Q4 2024 for Coya Therapeutics, roughly flat from $21500.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $21500.0 in Q2 2024 to a low of $16500.0 in Q1 2023.